September 3, 2021
Checkmate Pharmaceuticals, a clinical stage immuno-oncology company, is focused on pioneering new medicines for combating melanoma, non-melanoma skin cancers, and head and neck cancer. Dr. James Wooldridge, Chief Medical Officer, has partnered with The Chase Group on executive search projects because of the thoroughness, productivity, and expert evaluations he receives from Chase as he builds out his clinical development and regulatory affairs teams at this fast-moving startup.
Continue Reading →